Platelet aggregation inhibitor from Murraya euchrestifolia

Tian-Shung Wu, Yu Yi Chan, Meei Jen Liou, Ful Wen Lin, Li Shian Shi, Kuo Tung Chen

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

Twenty-three carbazole alkaloids, murrayafoline-A (1), 3-methyl- carbazole (2), murrayanine (3), mukoeic acid (4), murrayazolidine (5), bicyclomahanimbine (6), murrayamine-A (10), -D (13), -E (14), -F (15), -I (16), -J (17), -K (18), -M (7), -N (19), murrayazoline (8), girinimbine (9), mahanimbine (11), (+)-mahanine (12), isomahanine (20), murrafoline-A (21), - B (22) and bismurrayafoline-A (23) and a triterpenoid, friedelin together with β-sitosterol were isolated and characterized from the leaves and root bark of M. euchrestifolia. Their structures were elucidated by spectroscopic analyses and/or direct comparison with authentic samples. The isolated carbazole alkaloids 1-12 were subjected to evaluation for antiplatelet aggregation activity and vasorelaxing effect. Most of the isolated carbazole alkaloids showed potent inhibitory, activity on rabbit platelet aggregation induced by arachidonic acid (100 μM), collagen (10 μg/mL) and PAF (2 ng/mL). Only murrayafoline-A (1) showed inhibition of tonic contraction induced by K+ (80 mM) + Ca2+ (1.9 mM). Compounds 1, 7 and 12 showed the promotion of the platelet aggregation or lysis at high dose. In contrast, they also exhibited antiplatelet aggregation activity at low concentration. This result could continue the philosophy of use in Chinese medicine, in that the dose variation in a prescription produced different, promotive or inhibitive, effects on therapy.

Original languageEnglish
JournalPhytotherapy Research
Volume12
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 1998 Jan 1

All Science Journal Classification (ASJC) codes

  • Pharmacology

Fingerprint Dive into the research topics of 'Platelet aggregation inhibitor from Murraya euchrestifolia'. Together they form a unique fingerprint.

Cite this